InvestorsHub Logo
Followers 572
Posts 9510
Boards Moderated 1
Alias Born 09/03/2004

Re: SPARK post# 274

Monday, 09/27/2010 6:20:55 AM

Monday, September 27, 2010 6:20:55 AM

Post# of 476
Yes, he has about 200 patients that no longer need any further treatments after about 18 months. There are 3 or 4 of us who need on going treatment. However word of mouth brings more in every day.

Another new development in OTC pain relief was the introduction of Cobroxin last year. A derivative of Asian Cobra Venonom is used to block the nicotinic receptor in the brain stem utilizing a Homeopathic oral spray. There are no side affects, no addiction, no stomach issues, no cardiovascular impact and will even stop migraine headaches in most people. Cost is under $20 for a months supply if used every day. In addition, the receptor becomes more receptive over time so you use less product over time unlike addictive opids. http://www.cobroxin.com http://www.nutrapharma.com trading at 18 cents a share.

World wide release coming soon under the name Nyloxin with a more powerful version for extreme pain and under strict doctors care. http://www.nyloxin.com

By the way, their subsidiary, Receptofarm is in clinical trials with cobra venom to treat MS. Phase one early indications stopped and even reversed symptoms in some patients. Further trials will probably start in 2012. http://www.receptopharm.com
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.